Eplerenone ameliorates the phenotypes of metabolic syndrome with NASH in liver-specific SREBP-1c Tg mice fed high-fat and high-fructose diet

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751 · see citing works

Obesity, Inflammation, and Insulin Resistance

Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806 · see citing works

AGA technical review on nonalcoholic fatty liver disease

Sanyal, A. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36572 · Cited by 1,072 · see citing works

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P. A., Moser, A. B., Desimone, C., Song, X.-Y., & Diehl, A. M. (2003) · Hepatology · doi:10.1053/jhep.2003.50048 · Cited by 930 · see citing works

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

Ouyang, X., Cirillo, P., Sautin, Y. Y., McCall, S. J., Bruchette, J. L., Diehl, A. M., Johnson, R. J., & Abdelmalek, M. F. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.02.011 · Cited by 862 · see citing works

Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells.

Shimano, H., Horton, J. D., Shimomura, I., Hammer, R. E., Brown, M. S., & Goldstein, J. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119248 · Cited by 842 · see citing works

Increased Fructose Consumption Is Associated With Fibrosis Severity in Patients With Nonalcoholic Fatty Liver Disease

Abdelmalek, M. F., Suzuki, A., Guy, C. D., Ünalp–Arida, A., Colvin, R., Johnson, R. J., & Diehl, A. M. (2010) · Hepatology · doi:10.1002/hep.23535 · Cited by 767 · see citing works

Regulatory Mechanisms for Adipose Tissue M1 and M2 Macrophages in Diet-Induced Obese Mice

Fujisaka, S., Usui, I., Bukhari, A., Ikutani, M., Oya, T., Kanatani, Y., Tsuneyama, K., Nagai, Y., Takatsu, K., Urakaze, M., et al. (2009) · Diabetes · doi:10.2337/db08-1475 · Cited by 715 · see citing works

Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance

Huang, W., Metlakunta, A., Dedousis, N., Zhang, P., Sipula, I., Dube, J. J., Scott, D. K., & O'Doherty, R. M. (2010) · Diabetes · doi:10.2337/db09-0016 · Cited by 520 · see citing works

Animal models of nonalcoholic fatty liver disease

Hebbard, L., & George, J. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.191 · Cited by 495 · see citing works

Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice

Usher, M. G., Duan, S. Z., Ivaschenko, C. Y., Frieler, R. A., Berger, S., Schütz, G., Lumeng, C. N.-K., & Mortensen, R. M. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41080 · Cited by 385 · see citing works

Nonalcoholic Fatty Liver Disease: Cytokine-Adipokine Interplay and Regulation of Insulin Resistance

Tilg, H., & Hotamışlıgil, G. S. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.054 · Cited by 385 · see citing works

Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-γ, and Proinflammatory Adipokines

Guo, C., Ricchiuti, V., Lian, B. Q., Yao, T. M., Coutinho, P., Romero, J. R., Li, J., Williams, G. H., & Adler, G. K. (2008) · Circulation · doi:10.1161/circulationaha.107.748640 · Cited by 342 · see citing works

Cytokine regulation of liver injury and repair

Diehl, A. M. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017411.x · Cited by 301 · see citing works

Angiotensin II-induced NADPH Oxidase Activation Impairs Insulin Signaling in Skeletal Muscle Cells

Wei, Y., Sowers, J. R., Nistala, R., Gong, H., Uptergrove, G. M., Clark, S. E., Morris, E. M., Szary, N. M., Manrique, C. M., & Stump, C. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601320200 · Cited by 297 · see citing works

Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis

Kisseleva, T., & Brenner, D. A. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04658.x · Cited by 286 · see citing works

The renin-angiotensin-aldosterone system, glucose metabolism and diabetes

Giacchetti, G., Sechi, L. A., Rilli, S., & Carey, R. M. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.02.003 · Cited by 267 · see citing works

Endocrine and metabolic effects of consuming beverages sweetened with fructose, glucose, sucrose, or high-fructose corn syrup

Stanhope, K. L., & Havel, P. J. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.25825d · Cited by 237 · see citing works

Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice

Hirata, A., Maeda, N., Hiuge, A., Hibuse, T., Fujita, K., Okada, T., Kihara, S., Funahashi, T., & Shimomura, I. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp191 · Cited by 235 · see citing works

The Heme Oxygenase-1/Carbon Monoxide Pathway Suppresses TLR4 Signaling by Regulating the Interaction of TLR4 with Caveolin-1

Wang, X. M., Kim, H. P., Nakahira, K., Ryter, S. W., & Choi, A. M. K. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0712437 · Cited by 227 · see citing works

Recent advances in nonalcoholic fatty liver disease

Cheung, O., & Sanyal, A. J. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283294a18 · Cited by 218 · see citing works

Glucocorticoids exert opposing effects on macrophage function dependent on their concentration

Lim, H., Müller, N., Herold, M. J., van den Brandt, J., & Reichardt, H. M. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02611.x · Cited by 218 · see citing works

SREBPs: physiology and pathophysiology of the SREBP family

Shimano, H. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06806.x · Cited by 202 · see citing works

Angiotensin II and the development of insulin resistance: Implications for diabetes

Olivares-Reyes, J. A., Arellano-Plancarte, A., & Castillo-Hernández, J. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.12.011 · Cited by 202 · see citing works

Spironolactone Improves Glucose and Lipid Metabolism by Ameliorating Hepatic Steatosis and Inflammation and Suppressing Enhanced Gluconeogenesis Induced by High-Fat and High-Fructose Diet

Wada, T., Kenmochi, H., Miyashita, Y., Sasaki, M., Ojima, M., Sasahara, M., Koya, D., Tsuneki, H., & Sasaoka, T. (2010) · Endocrinology · doi:10.1210/en.2009-0869 · Cited by 189 · see citing works

Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease

Mitsuyoshi, H., Yasui, K., Harano, Y., Endo, M., Tsuji, K., Minami, M., Itoh, Y., Okanoue, T., & Yoshikawa, T. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00464.x · Cited by 172 · see citing works

Aldosterone and inflammation

Gilbert, K. C., & Brown, N. J. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283391989 · Cited by 161 · see citing works

Local Renal Aldosterone System and Its Regulation by Salt, Diabetes, and Angiotensin II Type 1 Receptor

Xue, C., & Siragy, H. M. (2005) · Hypertension · doi:10.1161/01.hyp.0000175814.18550.c0 · Cited by 122 · see citing works

Aldosterone Inhibits Insulin-Induced Glucose Uptake by Degradation of Insulin Receptor Substrate (IRS) 1 and IRS2 via a Reactive Oxygen Species-Mediated Pathway in 3T3-L1 Adipocytes

Wada, T., Ohshima, S., Fujisawa, E., Koya, D., Tsuneki, H., & Sasaoka, T. (2008) · Endocrinology · doi:10.1210/en.2008-1018 · Cited by 113 · see citing works

Central versus peripheral impact of estradiol on the impaired glucose metabolism in ovariectomized mice on a high-fat diet

Yonezawa, R., Wada, T., Matsumoto, N., Morita, M., Sawakawa, K., Ishii, Y., Sasahara, M., Tsuneki, H., Saito, S., & Sasaoka, T. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00638.2011 · Cited by 108 · see citing works

Caveolin-1-Deficient Mice Show Defects in Innate Immunity and Inflammatory Immune Response during Salmonella enterica Serovar Typhimurium Infection

Medina, F. A., de Almeida, C. J., Dew, E., Li, J., Bonuccelli, G., Williams, T. M., Cohen, A. W., Pestell, R. G., Frank, P. G., Tanowitz, H. B., et al. (2006) · Infection and Immunity · doi:10.1128/iai.00949-06 · Cited by 96 · see citing works

Evaluation and management of obesity-related nonalcoholic fatty liver disease

Nugent, C., & Younossi, Z. M. (2007) · Nature Clinical Practice Gastroenterology &#38 Hepatology · doi:10.1038/ncpgasthep0879 · Cited by 94 · see citing works

Recent advances in nonalcholic fatty liver disease

Greenfield, V., Cheung, O., & Sanyal, A. J. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3282fbccf2 · Cited by 94 · see citing works

Cell cycle synchronization of animal cells and nuclei by centrifugal elutriation

Bánfalvi, G. (2008) · Nature Protocols · doi:10.1038/nprot.2008.34 · Cited by 91 · see citing works

Contribution of glucocorticoid–mineralocorticoid receptor pathway on the obesity-related adipocyte dysfunction

Hirata, A., Maeda, N., Nakatsuji, H., Hiuge-Shimizu, A., Okada, T., Funahashi, T., & Shimomura, I. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.139 · Cited by 88 · see citing works

Genetically modified mouse models for the study of nonalcoholic fatty liver disease

Nagarajan, P. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i11.1141 · Cited by 79 · see citing works

Glucocorticoid pretreatment induces cytokine overexpression and nuclear factor-κB activation in macrophages

Smyth, G. P., Stapleton, P. P., Freeman, T. A., Concannon, E. M., Mestre, J. R., Duff, M., Maddali, S., & Daly, J. M. (2004) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00300-7 · Cited by 72 · see citing works

Impact of the Liver-Specific Expression of SHIP2 (SH2-Containing Inositol 5′-Phosphatase 2) on Insulin Signaling and Glucose Metabolism in Mice

Fukui, K., Wada, T., Kagawa, S., Nagira, K., Ikubo, M., Ishihara, H., Kobayashi, M., & Sasaoka, T. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1958 · Cited by 59 · see citing works

Single Nucleotide Polymorphism (–468 Gly to Ala) at the Promoter Region of Sterol Regulatory Element-binding Protein-1c Associates with Genetic Defect of Fructose-induced Hepatic Lipogenesis

Nagata, R., Nishio, Y., Sekine, O., Nagai, Y., Maeno, Y., Ugi, S., Maegawa, H., & Kashiwagi, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309449200 · Cited by 59 · see citing works

Chronic Nicotine Exposure Enhances Insulin-Induced Mitogenic Signaling via Up-Regulation of α7 Nicotinic Receptors in Isolated Rat Aortic Smooth Muscle Cells

Wada, T., Naito, M., Kenmochi, H., Tsuneki, H., & Sasaoka, T. (2006) · Endocrinology · doi:10.1210/en.2006-0907 · Cited by 58 · see citing works

Vascular proinflammatory responses by aldosterone are mediated via c-Src trafficking to cholesterol-rich microdomains: role of PDGFR

Callera, G. E., Yogi, Á., Briones, A. M., Montezano, A. C. I., He, Y., Tostes, R. C., Schiffrin, E. L., & Touyz, R. M. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr131 · Cited by 54 · see citing works

The extracellular matrix and insulin resistance

Williams, A. S., Kang, L., & Wasserman, D. H. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.05.006 · Cited by 228 · see citing works

Metabolic Targets in Nonalcoholic Fatty Liver Disease

Esler, W. P., & Bence, K. K. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.04.007 · Cited by 142 · see citing works

Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis

Pοlyzos, S. A., Kang, E. S., Boutari, C., Rhee, E., & Mantzoros, C. S. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154203 · Cited by 139 · see citing works

The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease

Romero, F. A., Jones, C. T., Xu, Y., Fenaux, M., & Halcomb, R. L. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01701 · Cited by 126 · see citing works

In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal

Soret, P.-A., Magusto, J., Housset, C., & Gautheron, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm10010036 · Cited by 121 · see citing works

Effects of aldosterone on insulin sensitivity and secretion

Luther, J. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.016 · Cited by 114 · see citing works

Adipocyte Mineralocorticoid Receptor Activation Leads to Metabolic Syndrome and Induction of Prostaglandin D2 Synthase

Urbanet, R., Nguyen Dinh Cat, A., Feraco, A., Venteclef, N., El Mogrhabi, S., Sierra-Ramos, C., Alvarez de la Rosa, D., Adler, G. K., Quilliot, D., Rossignol, P., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04981 · Cited by 114 · see citing works

Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction

Salah, H. M., Pandey, A., Soloveva, A. E., Abdelmalek, M. F., Diehl, A. M., Moylan, C. A., Wegermann, K., Rao, V. N., Hernandez, A. F., Tedford, R. J., et al. (2021) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2021.07.010 · Cited by 106 · see citing works

PDGFRβ Regulates Adipose Tissue Expansion and Glucose Metabolism via Vascular Remodeling in Diet-Induced Obesity

Onogi, Y., Wada, T., Kamiya, C., Inata, K., Matsuzawa, T., Inaba, Y., Kimura, K., Inoue, H., Yamamoto, S., Ishii, Y., et al. (2017) · Diabetes · doi:10.2337/db16-0881 · Cited by 93 · see citing works

Effects of combined low‐dose spironolactone plus vitamin E vs vitamin E monotherapy on insulin resistance, non‐invasive indices of steatosis and fibrosis, and adipokine levels in non‐alcoholic fatty liver disease: a randomized controlled trial

Pοlyzos, S. A., Kountouras, J., Mantzoros, C. S., Polymerou, V., & Katsinelos, P. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12989 · Cited by 78 · see citing works

Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease

Wang, Z., Zhu, S., Jia, Y., Wang, Y., Kubota, N., Fujiwara, N., Gordillo, R., Lewis, C., Zhu, M., Sharma, T., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.014 · Cited by 72 · see citing works

Mineralocorticoid receptor in adipocytes and macrophages: A promising target to fight metabolic syndrome

Marzolla, V., Armani, A., Feraco, A., Martino, M. U. D., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2014) · Steroids · doi:10.1016/j.steroids.2014.05.001 · Cited by 70 · see citing works

Eplerenone prevented obesity-induced inflammasome activation and glucose intolerance

Wada, T., Ishikawa, A., Watanabe, E., Nakamura, Y., Aruga, Y., Hasegawa, H., Onogi, Y., Honda, H., Nagai, Y., Takatsu, K., et al. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0351 · Cited by 69 · see citing works

Beneficial effects of mineralocorticoid receptor blockade in experimental non‐alcoholic steatohepatitis

Pizarro, M., Solís, N., Quintero, P., Barrera, F., Cabrera, D., Rojas‐de Santiago, P., Arab, J. P., Padilla, O., Roa, J. C., Moshage, H., et al. (2015) · Liver International · doi:10.1111/liv.12794 · Cited by 66 · see citing works

Role of Steroid Hormones in the Pathogenesis of Nonalcoholic Fatty Liver Disease

Yang, M., Ma, F., & Guan, M. (2021) · Metabolites · doi:10.3390/metabo11050320 · Cited by 59 · see citing works

An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present

Jacobs, A., Warda, A., Verbeek, J., Cassiman, D. M., & Spincemaille, P. (2016) · Current Protocols in Mouse Biology · doi:10.1002/cpmo.3 · Cited by 57 · see citing works

Developmental and extrahepatic physiological functions of SREBP pathway genes in mice

Engelking, L. J., Cantoria, M. J., Xu, Y., & Liang, G. (2017) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.07.011 · Cited by 56 · see citing works

Emerging and future therapies for nonalcoholic steatohepatitis in adults

Mintziori, G., & Pοlyzos, S. A. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1225727 · Cited by 50 · see citing works

Integrin α1-null Mice Exhibit Improved Fatty Liver When Fed a High Fat Diet Despite Severe Hepatic Insulin Resistance

Williams, A. S., Kang, L., Zheng, J., Grueter, C. A., Bracy, D. P., James, F. D., Pozzi, A., & Wasserman, D. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.615716 · Cited by 49 · see citing works

Effect of Training Intensity on Nonalcoholic Fatty Liver Disease

Cho, J., Kim, S., Lee, S., & Kang, H. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000595 · Cited by 46 · see citing works

Links between aldosterone excess and metabolic complications: A comprehensive review

Bothou, C., Beuschlein, F., & Spyroglou, A. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.02.003 · Cited by 46 · see citing works

Hepatic manifestations of women with polycystic ovary syndrome

Chen, M., & Ho, H. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.03.003 · Cited by 45 · see citing works

The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α

Ren, T., Zhu, J., Zhu, L., & Cheng, M. (2017) · Nutrients · doi:10.3390/nu9030198 · Cited by 41 · see citing works

Integrated Liver and Plasma Proteomics in Obese Mice Reveals Complex Metabolic Regulation

Stocks, B., González-Franquesa, A., Borg, M. L., Björnholm, M., Niu, L., Zierath, J. R., & Deshmukh, A. S. (2022) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2022.100207 · Cited by 36 · see citing works

The mineralocorticoid receptor—an emerging player in metabolic syndrome?

Thuzar, M., & Stowasser, M. (2021) · Journal of Human Hypertension · doi:10.1038/s41371-020-00467-3 · Cited by 38 · see citing works

Activation of Kupffer Cells Is Associated with a Specific Dysbiosis Induced by Fructose or High Fat Diet in Mice

Ferrere, G., Leroux, A., Wrzosek, L., Puchois, V., Gaudin, F., Ciocan, D. M., Renoud, M.-L., Naveau, S., Perlemuter, G., & Cassard, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146177 · Cited by 36 · see citing works

Role of Mineralocorticoid Receptor in Adipogenesis and Obesity in Male Mice

Ferguson, D., Hutson, I., Tycksen, E., Pietka, T., Bauerle, K. T., & Harris, C. A. (2019) · Endocrinology · doi:10.1210/endocr/bqz010 · Cited by 34 · see citing works

From Liver Fat to Cancer: Perils of the Western Diet

Kim, J. Y., He, F., & Karin, M. (2021) · Cancers · doi:10.3390/cancers13051095 · Cited by 25 · see citing works

Oxymatrine alleviated hepatic lipid metabolism via regulating miR-182 in non-alcoholic fatty liver disease

Zhang, H., Yang, L., Wang, Y., Huang, W., Yang, L., Chen, S., Song, G., & Ren, L. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118090 · Cited by 31 · see citing works

Protein phosphatase 4 (PP4) functions as a critical regulator in tumor necrosis factor (TNF)-α-induced hepatic insulin resistance

Zhao, H., Huang, X., Jiao, J., Zhang, H., Liu, J., Qin, W., Meng, X., Shen, T., Lin, Y., Chu, J., et al. (2015) · Scientific Reports · doi:10.1038/srep18093 · Cited by 30 · see citing works

Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial (MIRAD trial)

Johansen, M. L., Schou, M., Rossignol, P., Holm, M. R., Rasmussen, J., Brandt, N., Frandsen, M. N., Chabanova, E., Dela, F., Faber, J. O., et al. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13809 · Cited by 29 · see citing works

Selenium-Enriched Probiotic Alleviates Western Diet-Induced Non-alcoholic Fatty Liver Disease in Rats via Modulation of Autophagy Through AMPK/SIRT-1 Pathway

Pant, R., Sharma, N., Kabeer, S. W., Sharma, S., & Tikoo, K. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03247-x · Cited by 29 · see citing works

Impact of inflammation and anti-inflammatory modalities on diabetic cardiomyopathy healing: From fundamental research to therapy

Zhang, X., Han, X.-W., Jiang, Y., Wang, Y., He, X.-L., Liu, D., Huang, J., Liu, H.-H., Ye, T., Li, S.-J., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110747 · Cited by 29 · see citing works

Efficacy and safety of apararenone (MT‐3995) in patients with nonalcoholic steatohepatitis: A randomized controlled study

Okanoue, T., Sakamoto, M., Harada, K., Inagaki, M., Totsuka, N., Hashimoto, G., & Kumada, H. (2021) · Hepatology Research · doi:10.1111/hepr.13695 · Cited by 28 · see citing works

Secondary diabetes mellitus due to primary aldosteronism

Moustaki, M., Paschou, S. Α., Vakali, E., & Vryonidou, A. (2022) · Endocrine · doi:10.1007/s12020-022-03168-8 · Cited by 28 · see citing works

A Mineralocorticoid Receptor Deficiency in Myeloid Cells Reduces Liver Steatosis by Impairing Activation of CD8+ T Cells in a Nonalcoholic Steatohepatitis Mouse Model

Muñoz-Durango, N., Arrese, M., Hernández, A., Jara, E. L., Kalergis, A., & Cabrera, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.563434 · Cited by 24 · see citing works

HFpEF and MASLD: converging mechanisms and clinical implications

Capone, F., Häseli, S. P., Liu, L., Strocchi, S., Langenberg, C., Lusis, A. J., Pietzner, M., Muoio, D. M., Rider, O. J., Raman, B., et al. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01257-z · Cited by 31 · see citing works

Nuciferine prevents hepatic steatosis by regulating lipid metabolismin diabetic rat model

Ning, Q., Wang, Y., Zhang, Y., Shen, G., Xie, Z., & Pang, J. (2019) · Open Life Sciences · doi:10.1515/biol-2019-0079 · Cited by 25 · see citing works

Significance of MR/OPN/HMGB1 axis in NAFLD-associated hepatic fibrogenesis

Tang, M., Jia, H., Chen, S., Yang, B., Patpur, B. K., Song, W., Chang, Y., Li, J., & Yang, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118619 · Cited by 25 · see citing works

Insulin‐like growth factor binding protein 7 accelerates hepatic steatosis and insulin resistance in non‐alcoholic fatty liver disease

Yan, H., Li, T., Wang, Y., Li, H., Xu, J., & Lu, X. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13159 · Cited by 24 · see citing works

Neonatal monosodium glutamate treatment causes obesity, diabetes, and macrovesicular steatohepatitis with liver nodules in DIAR mice

Tsuneyama, K., Nishida, T., Baba, H., Taira, S., Fujimoto, M., Nomoto, K., Hayashi, S., Miwa, S., Nakajima, T., Sutoh, M., et al. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12610 · Cited by 23 · see citing works

Preventive and chronic mineralocorticoid receptor antagonism is highly beneficial in obese SHHF rats

Youcef, G., Olivier, A., Nicot, N., Muller, A., Deng, C. Z., Labat, C., Fay, R., Guéant‐Rodriguez, R., Leroy, C., Jaisser, F., et al. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13479 · Cited by 21 · see citing works

Hypothalamic orexin prevents non-alcoholic steatohepatitis and hepatocellular carcinoma in obesity

Tsuneki, H., Maeda, T., Takata, S., Sugiyama, M., Otsuka, K., Ishizuka, H., Onogi, Y., Tokai, E., Koshida, C., Kon, K., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111497 · Cited by 21 · see citing works

Involvement of the extracellular matrix and integrin signalling proteins in skeletal muscle glucose uptake

Draicchio, F., Behrends, V., Tillin, N. A., Hurren, N. M., Sylow, L., & Mackenzie, R. (2022) · The Journal of Physiology · doi:10.1113/jp283039 · Cited by 20 · see citing works

Dietary high calories from sunflower oil, sucrose and fructose sources alters lipogenic genes expression levels in liver and skeletal muscle in rats

Özkan, H., & Yakan, A. (2019) · Annals of Hepatology · doi:10.1016/j.aohep.2019.03.013 · Cited by 20 · see citing works

Treatment of cigarette smoke extract and condensate differentially potentiates palmitic acid-induced lipotoxicity and steatohepatitis in vitro

Zhou, Z., Kim, J. W., Zhao, J., Qi, J., Choi, S. J., Lim, C. W., Lee, M., Lee, K., & Kim, B. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.05.017 · Cited by 19 · see citing works

Angiotensin II receptor blocker combined with eplerenone or hydrochlorothiazide for hypertensive patients with diabetes mellitus

Karashima, S., Yoneda, T., Kometani, M., Ohe, M., Mori, S., Sawamura, T., Furukawa, K., Yamagishi, M., & Takeda, Y. (2016) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2016.1151526 · Cited by 15 · see citing works

Mineralocorticoid receptor modulation by dietary sodium influences NAFLD development in mice

Cabrera, D., Rao, I., Raasch, F., Solı́s, N., Pizarro, M., Freire, M., de Urturi, D. S., Ramírez, C., Triantafilo, N., León, J., et al. (2021) · Annals of Hepatology · doi:10.1016/j.aohep.2021.100357 · Cited by 14 · see citing works

Teneligliptin improves metabolic abnormalities in a mouse model of postmenopausal obesity

Sameshima, A., Wada, T., Ito, T., Kashimura, A., Sawakawa, K., Yonezawa, R., Tsuneki, H., Ishii, Y., Sasahara, M., Saito, S., et al. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0239 · Cited by 14 · see citing works

Evaluation of Nonalcoholic Fatty Liver Disease in C57BL/6J Mice by Using MRI and Histopathologic Analyses.

Ryu, J.-E., Jo, W., Choi, H., Jang, S., Lee, H.-J., Woo, D.-C., Kim, J. K., Kim, K. W., Yu, E. S., & Son, W. (2015) · PubMed Central · Cited by 13 · see citing works

Spironolactone in Combination with α-glycosyl Isoquercitrin Prevents Steatosis-related Early Hepatocarcinogenesis in Rats through the Observed NADPH Oxidase Modulation

Murayama, H., Eguchi, A., Nakamura, M., Kawashima, M., Nagahara, R., Mizukami, S., Kimura, M., Makino, E., Takahashi, N., Ohtsuka, R., et al. (2018) · Toxicologic Pathology · doi:10.1177/0192623318778508 · Cited by 13 · see citing works

Inhibition of Col6a5 Improve Lipid Metabolism Disorder in Dihydrotestosterone-Induced Hyperandrogenic Mice

Sun, L.-F., Yang, Y., Wang, M.-Y., Zhao, H., Xiao, T., Li, M., Wang, B.-B., Huang, C. Y., Ren, P., & Zhang, J. V. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.669189 · Cited by 10 · see citing works

Aldosterone: a cardiometabolic risk hormone?

Pereira, P. F., Priore, S. E., & Bressan, J. (2014) · PubMed · doi:10.3305/nh.2014.30.6.7725 · Cited by 10 · see citing works

The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic Rats

Hsu, S., Wang, S.-S., Huo, T., Lee, F., Huang, H., Chang, C.-C., Hsin, I., Ho, H., Lin, H., & Lee, S. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.225516 · Cited by 8 · see citing works

Drug–Drug Interactions of the Nonsteroidal Mineralocorticoid Receptor Antagonist Apararenone With Midazolam, Warfarin, and Digoxin: A Phase 1 Studies in Healthy Volunteers

Nakamura, T., Shimizu, H., & Kawaguchi, A. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.09.002 · Cited by 7 · see citing works

The Metabolic Dysfunction–Associated Steatotic Liver Disease–CKD Axis: Intersecting Pathways and Opportunities for Early Intervention

Sriperumbuduri, S., Saravanan, P. B., Gupta, G., & Sanyal, A. J. (2025) · Kidney International Reports · doi:10.1016/j.ekir.2025.103757 · Cited by 7 · see citing works

Elevated plasma aldosterone is an independent risk factor for erectile dysfunction in men

Wu, F., Mao, S., Yu, T., Jiang, H., Ding, Q., & Xu, G. (2015) · World Journal of Urology · doi:10.1007/s00345-015-1723-0 · Cited by 6 · see citing works

Guideline-directed medical strategies for the co-management of heart failure and metabolic dysfunction-associated steatotic liver disease

Gries, J. J., Chen, B., Bansal, M. B., Rodríguez, M., Alqahtani, S. A., Brennan, P., Lang, C. C., Tang, W. H. W., Lazarus, J. V., & Krittanawong, C. (2025) · Communications Medicine · doi:10.1038/s43856-025-00951-2 · Cited by 6 · see citing works

Esaxerenone, a selective mineralocorticoid receptor blocker, improves insulin sensitivity in mice consuming high-fat diet

Bavuu, O., Fukuda, D., Ganbaatar, B., Matsuura, T., Ise, T., Kusunose, K., Yamaguchi, K., Yagi, S., Yamada, H., Soeki, T., et al. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175190 · Cited by 5 · see citing works

Therapies for patients with coexisting heart failure with reduced ejection fraction and non-alcoholic fatty liver disease

Arriola‐Montenegro, J., Beas, R., Cerna-Viacava, R., Chapoñan-Lavalle, A., Randich, K. H., Chambergo‐Michilot, D., Sanga, H. F., & Mutirangura, P. (2023) · World Journal of Cardiology · doi:10.4330/wjc.v15.i7.328 · Cited by 5 · see citing works

Renin-independent aldosteronism and metabolic dysfunction-associated steatotic liver disease and cirrhosis: A genetic association study

Zeng, Q., Luo, X., Chen, X., Luo, W., Li, R., Yang, S., Yang, J., Shu, X., Li, Q., Hu, J., et al. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.12.011 · Cited by 5 · see citing works

Role of Angiogenesis and Chronic Inflammation in Fat Hypertrophy in NASH Pathology

Wada, T., Tsuneki, H., & Sasaoka, T. (2019) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.19-00011-3 · Cited by 5 · see citing works

Unanticipated increases in hepatic steatosis among human immunodeficiency virus patients receiving mineralocorticoid receptor antagonist eplerenone for non‐alcoholic fatty liver disease

Chaudhury, C. S., Purdy, J., Liu, C., Morse, C. G., Stanley, T. L., Kleiner, D. E., & Hadigan, C. M. (2018) · Liver International · doi:10.1111/liv.13734 · Cited by 5 · see citing works

The Role of Aldosterone and the Mineralocorticoid Receptor in Metabolic Dysfunction-Associated Steatotic Liver Disease

Barigou, M., Ramzan, I., & Chartoumpekis, D. V. (2025) · Biomedicines · doi:10.3390/biomedicines13081792 · Cited by 4 · see citing works

Eplerenone–A novel Mineralocorticoid receptor antagonist for the clinical application

Wu, N., Zhang, Y.-Y., & Zhao, D. (2022) · Environmental Disease · doi:10.4103/ed.ed_7_21 · Cited by 4 · see citing works

Visceral adiposity as a predictor of new-onset diabetes in patients with primary aldosteronism: a cohort study

Chu, W.-K., Er, L., Chang, C., Lu, J., Wu, W.-C., Tsai, Y., Lin, Y., & Wu, V. (2024) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223241301892 · Cited by 2 · see citing works

A transdermal treatment with MC903 ameliorates diet-induced obesity by reducing visceral fat and increasing myofiber thickness and energy consumption in mice

Wada, T., Miyazawa, Y., Ikurumi, M., Fuse, K., Okekawa, A., Onogi, Y., Saito, S., Tsuneki, H., & Sasaoka, T. (2023) · Nutrition & Metabolism · doi:10.1186/s12986-023-00732-5 · Cited by 2 · see citing works

Impact of Endocrine Disorders on the Liver

Ciaula, A. D., Christidis, G., Krawczyk, M. J., Lammert, F., & Portincasa, P. (2020) · Endocrinology · doi:10.1007/978-3-319-66362-3_6-1 · Cited by 1 · see citing works

Impact of Endocrine Disorders on the Liver

Ciaula, A. D., Christidis, G., Krawczyk, M. J., Lammert, F., & Portincasa, P. (2020) · Endocrinology · doi:10.1007/978-3-319-68729-2_6 · Cited by 1 · see citing works

Kill two birds with one stone: Hapatologist’s approach to metabolic dysfunction-associated steatotic liver disease and heart failure

Hirao, Y., Morihara, C., & Sempokuya, T. (2024) · World Journal of Cardiology · doi:10.4330/wjc.v16.i11.660 · Cited by 1 · see citing works

Kupffer cells

Kiyani, A., & Seki, E. (2015) · doi:10.1002/9781118663387.ch4 · Cited by 1 · see citing works

Esaxerenone improves the blood pressure and metabolic parameters of hypertensive subjects with diabetes

Kuwabara, S., Kameda, H., Yokozeki, K., Miya, A., Nomoto, H., Cho, K. Y., Nakamura, A., Koyanagawa, N., Yamamoto, K., Takeuchi, J., et al. (2025) · Endocrine Journal · doi:10.1507/endocrj.ej24-0639

Additional file 2 of A transdermal treatment with MC903 ameliorates diet-induced obesity by reducing visceral fat and increasing myofiber thickness and energy consumption in mice

Wada, T., Miyazawa, Y., Ikurumi, M., Fuse, K., Okekawa, A., Onogi, Y., Saito, S., Tsuneki, H., & Sasaoka, T. (2024) · Figshare · doi:10.6084/m9.figshare.26567986

Additional file 3 of A transdermal treatment with MC903 ameliorates diet-induced obesity by reducing visceral fat and increasing myofiber thickness and energy consumption in mice

Wada, T., Miyazawa, Y., Ikurumi, M., Fuse, K., Okekawa, A., Onogi, Y., Saito, S., Tsuneki, H., & Sasaoka, T. (2024) · Figshare · doi:10.6084/m9.figshare.26567989

Additional file 1 of A transdermal treatment with MC903 ameliorates diet-induced obesity by reducing visceral fat and increasing myofiber thickness and energy consumption in mice

Wada, T., Miyazawa, Y., Ikurumi, M., Fuse, K., Okekawa, A., Onogi, Y., Saito, S., Tsuneki, H., & Sasaoka, T. (2024) · Figshare · doi:10.6084/m9.figshare.26567983

The impact of mineralocorticoid receptor antagonists on fat mass and fat metabolism

Afşar, B., Afşar, R. E., & Maddukuri, G. S. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-02909-0

The Mineralocorticoid Receptor and Its Antagonist Finerenone Regulate Hepatic Lipid Accumulation via the AMPK/SREBP1/FASN Signaling.

Fu, S.-P., Zhang, M.-Y., Wang, K., Huang, S., Xi, Y.-M., Chen, J.-Y., Xie, D., Zhang, Q., Que, W.-L., Ye, X.-L., et al. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112845

Regulation of the Mineralocorticoid Receptor in Physiology and Disease

Young, M. J., Fuller, P. J., Meijer, O. C., Cole, T. J., Kanki, M., Yang, J., Ho, Q. V., Karthigan, N., & Heanue, S. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100156

Targeting the aldosterone–mineralocorticoid receptor pathway in cardiovascular–kidney–metabolic syndrome

Sánchez‐Bayuela, T., Barrera‐Chimal, J., & Jaisser, F. (2026) · Nature Reviews Nephrology · doi:10.1038/s41581-026-01125-6

BindingDB Entry 50007641: The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease.

BindingDB (2021) · UC San Diego · doi:10.7270/q2dj5jxg

Beneficial effects of mineralocorticoid receptor blockade in experimental non‐alcoholic steatohepatitis

Pizarro, M., Solís, N., Quintero, P., Barrera, F., Cabrera, D., Rojas‐de Santiago, P., Arab, J. P., Padilla, O., Roa, J. C., Moshage, H., et al. (2015) · Liver International · doi:10.1111/liv.12794 · Cited by 66 · see citing works

エプレレノンは高脂肪食と高フルクトース食を与えられた肝臓特異的SREBP-1c Tgマウスにおける非アルコール性脂肪性肝炎(NASH)を伴う代謝症候群の表現型を改善する

Wada, T., Miyashita, Y., Sasaki, M., Aruga, Y., Yuto, N., Ishii, Y., Sasahara, M., Kanasaki, K., Kitada, M., Koya, D., et al. (2013) · American Journal of Physiology-Legacy Content

Adiponectin suppresses endoplasmic reticulum stress in nonalcoholic steatohepatitis

Ueno, T., Nakamura, A., Nakayama, H., Otabe, S., Yuan, X., Fukutani, T., Iwamoto, H., Nakamura, T., Koga, H., Torimura, T., et al. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.348 · Cited by 14 · see citing works

Einfluss des selektiven Aldosteron-Antagonisten Eplerenon auf das Renin-Angiotensin-Aldosteron-System und die Fibroseentwicklung im BDO-Modell der Ratte

Schulte, S., Scholz, P., Demir, M., Drebber, U., Töx, U., & Steffen, H. (2015) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0035-1559133

Comparative Effects of the Renin–Angiotensin System Blockers on Nonalcoholic Fatty Liver Disease and Insulin Resistance in C57Bl/6 Mice

Frantz, E. D. C., Penna‐de‐Carvalho, A., Batista, T. D. M., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0129 · Cited by 24 · see citing works